The FDA has Approved the First Oral Drug for Maintenance Therapy of High-Risk Neuroblastoma
source: shutterstock.com

The FDA has Approved the First Oral Drug for Maintenance Therapy of High-Risk Neuroblastoma

Neuroblastoma most commonly occurs in children under the age of five. The disease usually affects areas of the adrenal gland (positioned over the kidneys) or areas in the neck, chest,…

Continue Reading The FDA has Approved the First Oral Drug for Maintenance Therapy of High-Risk Neuroblastoma